2024 Executive War College Agenda

This was our 2024 Agenda, with announced session titles and speakers for the EWC Conference. This gives you an idea of the depth and the breath of our program each year.

Check back here in the fall for details on our 2025 conference

Monday   –   Tuesday   –   Wednesday   –   Thursday 

Executive War College Agenda Monday, April 20, 2024 to Thursday, Mary 2, 2024 from 7:00am to 7:00pm each day.

Monday, April 29 (Top)

REGISTRATION

4:00 PM - 7:30 PM

Early Registration 

RECEPTION

5:30 PM - 7:30 PM

Get Acquainted Reception

Tuesday, April 30 (Top)

Don't Miss these Keynote Speakers!

Tuesday General Session — 9:30 AM - 12:00 PM

GENERAL SESSION

9:30 AM - 10:00 AM

Big Changes in Healthcare: New Regulations and New Diagnostics Players Poised to Reshape Lab Testing

Lâle White CEO, XiFin, Inc.

Lâle White
Executive Chair & CEO,
XiFin, Inc.
San Diego, CA

GENERAL SESSION

10:00 AM - 10:15 AM

CDC Laboratory Update: CLIA Regulations, Resources for Clinical Laboratories, and More

Salerno Reynolds, PhD., Acting Director at CDC's Center for Laboratory Systems and Response

Reynolds Salerno
PhD,
Director, Division of Laboratory Systems,
U.S. Centers for Disease Control and Prevention (CDC),
Atlanta, CA

AM BREAK

10:15 AM - 10:35 AM

AM BREAK 

GENERAL SESSION

10:35 AM - 10:55 AM

MolDx and Z-identifier Codes: Why and How and the Future

Gabriel Bien-Willner, Medical Director, M0IDX program, Palmetto GBA

Gabriel Bien-Willner
MD, PhD
Dr.
Palmetto GBA,
Columbia, SC

GENERAL SESSION

10:55 AM - 11:15 AM

New Developments at the FDA: Draft LDT Rule, Harmonization of ISO 13485, Memo on Reclassification of Certain Assays, and More

Tim Stenzel, CEO, Grey Haven LLC

Tim Stenzel
CEO,
Grey Haven, LLC.
Crystal, MN

GENERAL SESSION

11:15 AM - 12:00 PM

Panel: Timing and Implications of FDA LDT Rule; Reforms to CLIA Regulations; Wider Use of Z-Code by Payers

Session Chair: William Morice

Chair & Moderator: William Morice
Panelists: Gabriel Bien-Willner, Tim Stenzel, Lâle White

William Morice President and CEO Mayo Clinic Laboratories

William Morice
MD, PhD,
President & CEO,
Mayo Clinic Laboratories,
Rochester, MN

Gabriel Bien-Willner, Medical Director, M0IDX program, Palmetto GBA

Gabriel Bien-Willner
MD, PhD
Dr.
Palmetto GBA,
Columbia, SC

Tim Stenzel, CEO, Grey Haven LLC

Tim Stenzel
CEO,
Grey Haven, LLC.
Crystal, MN

Lâle White CEO, XiFin, Inc.

Lâle White
Executive Chair & CEO,
XiFin, Inc.
San Diego, CA

Tuesday Morning — Management Master Classes & Benefactor Sessions

MASTER CLASS

7:30 AM - 8:20 AM

Price Transparency: What Labs Need to Know Now about Existing Regulations and Pending Legislation
Christopher Ho, MS, SVP Customer Operations Group, Myriad Genetics

Christopher Ho
MS,
SVP Customer Operations Group,
Myriad Genetics,
Salt Lake City, UT

Gregory Stein CEO, Shadowbox, Encinitas, CA

Gregory Stein
Founder & CEO,
Shadowbox,
Carlsbad, CA

Rachelle Galant, Chief Strategy Officer, Careviso

Rachelle Galant
Chief Strategy Officer,
Careviso,
Falls Church, VA

MASTER CLASS

7:30 AM - 8:20 AM​

Best Practices in Managing Point-of-Care Testing: Achieving a Single IT Infrastructure to Manage POCT Results in Inpatient and Ambulatory Settings

Jeanne Mumford
Manager, POCT,
Johns Hopkins Hospital,
Baltimore, MD

MASTER CLASS

7:30 AM - 8:20 AM​

Lessons Learned in Adapting Histology Processes to Support Scanning, High-Quality Whole Slide Images, and Digital Workflow

Raiza Valentin, Laboratory Manager, Coreplus Servicios Clinicos y Patologicos

Raiza Valentin
Laboratory Manager, 
Coreplus Servicios Clinicos y Patologicos,
Carolina, Puerto Rico

MASTER CLASS

7:30 AM - 8:20 AM​

Autonomous Robots in the Lab: Freeing FTEs and Shortening Lab Test Turnaround Times while Improving Quality and Patient Care

Sarah Province, Manager, Regional Laboratory Director, AdventHealth

Sarah Province
Regional Laboratory Director,
Florida Hospital – AdventHealth,
Orlando, FL

MASTER CLASS

7:30 AM - 8:20 AM​

Latest Trends in Managing Denials and Appeals of Clinical Lab and
Pathology Claims

Diana Richard, Sr. Director, Pathology and Strategic Development, XIFIN, San Diego, CA

Diana Richard
AVP, National Accounts, Path/Rad/Health Systems,
XiFin, Inc.
San Diego, CA

Stephanie Deham, Assoc Vice President, Revenue Cycle Management and Analytics at XFIN

Stephanie Denham
Associate Vice President,
RCM Systems and Analytics,
XiFin, Inc. 
San Diego, CA

MASTER CLASS

7:30 AM - 8:20 AM​

Making Data Actionable in RCM

Seth Maheu CEO, Birdrock LaboratoriesBirdrock Laboratories, San Diego, CA

Seth Maheu
CEO,
Birdrock Laboratories,
San Diego, CA

BENEFACTOR SESSIONS

7:30 AM - 8:20 AM

Coronis Health,  SYNERGEN Health,  Experian Health

BENEFACTOR SESSION

7:30 AM - 8:20 AM

Coronis Health

HEADWINDS in Lab&Path

This session hosted by Michael Ferrie with Jane Pine Wood, Counsel at McDonald Hopkins, focuses on key areas for consideration and action by laboratory and pathology professionals. An interactive presentation/discussion, topics include:

  • The Audits are Coming!
  • How Low is Low? Medicaid Reimbursement Travails
  • Key Trouble Spots — New & Returning
    • REQs signed
    • Special Payment Plans
    • OIG Hit List
  • Digital Pathology: key trends, TC/PC arrangements
  • “Arrangements” as pertain to billing, collections, & related matters
    • What does NOT work
    • Ways to get creative within boundaries
  • Payer News / Clearinghouse News
  • Protection from Cyber Attack — Implications and Precautions
  • Current Events as applicable
  • Open Q&A
Michael Ferrie, President, Laboratory & Pathology, Coronis Health

Michael Ferrie
MM/MBA,
President, Laboratory & Pathology,
Coronis Health,
Fenton, MO

BENEFACTOR SESSION

7:30 AM - 8:20 AM

SYNERGEN Health 

Maximize Lab Profitability: Unleash the Power of AI with Practical Use Cases

Transform your laboratory’s financial landscape using AI and technology that provide up to a 14% revenue increase and an 80% reduction in manual data entry costs. In our session, discover how SYNERGEN Health’s innovative, integrated revenue cycle solution and PreciseMDX’s AI Paperless Lab technology tackle the industry’s toughest challenges, from data quality to staffing shortages.

Through real-world examples, we’ll reveal the transformative power of AI in enhancing operational efficiencies and driving growth. Don’t miss the opportunity to unlock these game-changing benefits for your laboratory.

Suni Konda, Chief Product Officer, Synergen Health

Sunil Konda
Chief Product Officer,
SYNERGEN Health

Mark Dorner, Co-Founder & CEO, PreciseMDX

Mark Dorner
Co-Founder & CEO,
PreciseMDX

BENEFACTOR SESSION

7:30 AM - 8:20 AM

Experian Health

Revolutionizing Insurance Discovery in Lab RCM: Harness the Power of AI and Real-Time Data Correction

In the post-pandemic landscape, labs are grappling with the challenges of evolving patient populations and shifting insurance coverages – and doing it with fewer staff and tighter margins.

Fluid enrollments – when combined with ever-changing patient health plans – often result in messy and time-consuming claim denials. 2024 presents an optimal opportunity to take command of your revenue cycle management and proactively prevent future revenue leakage by embracing the right AI, machine learning and robotic process automation strategies that can make your rev cycle run like a well-oiled machine.

In this session, rev cycle stalwart and Wave HDC co-founder Dean Paluch and our guest panel of laboratory revenue cycle leaders will help you:

  • Understand the crucial role of a continual monitoring strategy during open enrollment periods to ensure financial success
  • Explore how real-time, automated data correction turns FTE-laden denial management teams into low-touch / no-touch denial prevention, limiting human resources investments
  • Strategize smart ways to explore real-time AI tools that deliver immediate ROI
  • Experience the financial impact of an insurance discovery client that avoided millions in potential denied claims and drove improved cash acceleration by using AI

Dean Paluch, VP of Sales, Experian Health

Dean Paluch
VP of Sales,
Experian Health,
Franklin, TN

MASTER CLASS

8:30 AM - 9:20 AM

How Real-Time Analytics Improved Lab Performance and Helped Reduce Readmissions Due to Fewer False Positives in Sepsis Testing

Regina Galloway, Manager of Clinical Pathology Laboratories, Ochsner Health

Regina Galloway
MLS(ASCP)
Manager of Clinical Pathology Laboratories, Ochsner Health,
New Orleans, LA

MASTER CLASS

8:30 AM - 9:20 AM

Standardizing and Automating Central Lab Testing Across 25 Laboratory Sites to Shorten Time-to-Answer, Reduce Staff Touches, and Improve Service to Physicians

Daniel Anderson Lab Manager Intermountain Health Salt Lake City Utah

Daniel Anderson 
Clinical Pathology Lab Manager,
Intermountain Health,
Murray, UT

Jamel Gluma JTG Consulting Group

Jamel Giuma
President & CEO,
JTG Consulting Group,
Miami Shores, FL

MASTER CLASS

8:30 AM - 9:20 AM

CLIA Laboratory Director Forum

Jon Harol, President, Lighthouse Lab Services

Jon Harol
President,
Lighthouse Lab Services,
Charlotte, NC

Lindsay Strotman, Laboratory Director at Lighthouse Laboratory Services

Lindsay Strotman
PhD,
Laboratory Director,
Lighthouse Lab Services,
Louisville, KY

MASTER CLASS

8:30 AM - 9:20 AM

New Opportunities to Deliver More Value With Lab Data in Medicare STARS and Risk Adjustment

Rick VanNess, Director, Product Management, TriCore Reference Laboratories, Albuquerque, NM

Rick VanNess
MS,
Director, Product Management,
TriCore Reference Laboratories,
Albuquerque, NM

MASTER CLASS

8:30 AM - 9:20 AM

Version 2.0: Small Lab Sites, Big Patient Impact! Delivering Lab Testing in Rural Areas to Stay Ahead of Infectious Disease Outbreaks, from STDs to Respiratory Viruses

Kristie Madden Laboratory Manager, United Indian Health Services

Kristie Madden
Laboratory Manager,
United Indian Health Services
Arcata, CA

MASTER CLASS

8:30 AM - 9:20 AM

Fine-Tuning Epic Beaker to Optimize Orders and Streamline Communication between Clinical Teams and Lab to Reduce Pre-Analytical Errors

Ryan Matos, Beaker & Reporting Expert, Honeydew Consulting

Ryan Matos
Beaker & Reporting Expert,
Honeydew Consulting,
South Burlington, VT

Kaylee Smith 
MIHM, MLS(ASCP)
Technical Specialist II – Microbiology 
Advocate Clinical Laboratories, Advocate Health,
Charlotte, NC

BENEFACTOR SESSIONS

8:30 AM - 9:20 AM

XiFin, Inc., ELLKAY, U.S. HealthTek

BENEFACTOR SESSION

8:30 AM - 9:20 AM

XiFin, Inc.

How AI Is Reshaping Revenue Cycle Management

Topic Description: Operating in an environment of ever-changing payor policies and behavior, finance and revenue cycle leaders must expand their understanding of how artificial intelligence (AI) can help them address operational and business issues, from an increase in denials to working errors more efficiently. In this session, Jeff Carmichael and Sandra Greefkes share learnings from AI projects, the need for automation as a foundation before applying AI, and the benefits of a more robust approach to AI-enabled RCM.  Jeff and Sandra will present a comprehensive and strategic approach to data, automation, and AI that can help your organization:

  1. Remove friction throughout the patient’s experience.
  2. Route errors based on payment risk or billing team member expertise.
  3. Leverage AI to translate various payor responses into the most appropriate reason code and next actions.

Participants will experience how various analytics and visualizations can help determine where to focus AI efforts and gain a deeper understanding of the practical applications of AI-enabled RCM workflow. Finally, participants will discover how AI can be applied to payor responses and the automation that can be garnered.

Jeff Carmichael, Senior Vice President, Engineering and Analytics, XiFin, Inc.

Jeff Carmichael 
SVP,
Engineering and Analytics,
XiFin, Inc.

Sandra Greefkes, VP Product and Partner Marketing XiFin, Inc.

Sandra Greefkes
VP,
Product and Partner Marketing,
XiFin, Inc.

BENEFACTOR SESSION

8:30 AM - 9:20 AM

ELLKAY 

Enhancing Healthcare Continuity for a Growth Oriented Health System and Reference Lab: Leveraging EMPi and a Complete Interoperability Platform to Achieve Automated and Efficient Laboratory Data Exchange

Explore how Intermountain Healthcare uses ELLKAY’s LKOrbit lab platform and upgraded interfaces to support their lab automation. Learn methods used to transform a multi-system laboratory outreach program using master patient index data, a single data management platform, and enhancing reference lab workflows with ARUP’s highly automated specimen intake processes, while highlighting the verato query and the interoperability component for distribution of all results.

Marci Dop, Strategic Advisor, ELLKAY, Elmwood Park, NJ

Marci Dop
Vice President Enterprise Lab Operations,
ELLKAY,
Elmwood Park, NJ

John Johnson
Senior Vice President, Sales,
ELLKAY,
Elmwood Park, NJ

Emily Shake, Director of Commercialization-Laboratory, Intermountain Health, Salt Lake City, UT

Emily Shake
Director of Commercialization-Laboratory,
Intermountain Health,
Salt Lake City, UT

Adam Barker, PhD, COO, ARUP Laboratories,

Adam Barker
PhD,
COO, ARUP Laboratories, 
Salt Lake City, UT

BENEFACTOR SESSION

8:30 AM - 9:20 AM

U.S. HealthTek

“Is AI going to take my job?”
The Real-World Impact of AI, Machine Learning, and Automation in Healthcare

U.S. HealthTek President and CTO Robert Negosian will be moderating a panel discussion focused on the utilization and impact of artificial intelligence (AI), machine learning and intelligent automation in healthcare organizations. Panelists will discuss implementation of these technologies, and the impact they can have on an organization big and small.

The discussion will cover topics including an overview on AI and machine-learning technologies, the decision-making process in how and when to utilize these tools, and their impacts on organizations. Panelists will also discuss typical challenges faced during implementation, including initial assumptions and gaps between assumptions and reality.

The goal is to provide attendees with a comprehensive overview of the practical applications of machine learning and AI tools, and to gain valuable insights from industry experts using these emerging technologies in the field today. The event will conclude with a Q&A session to address specific questions or comments from the audience.

Robert Negosian, President & CTO, U.S. Healthtek

Robert Negosian
MBA, PMP,
President & CTO,
U.S. HealthTek, Inc.
Haymarket, VA

Andy Moye, CEO, Paige, AI Cancer Diagnostics

Andy Moye,
PhD,
CEO,
Paige, AI Cancer Diagnostics,
Haymarket, VA

Greg Sorenson, CEO & Co-Founder, DeepHealth, Inc.

Greg Sorensen
MD,
CEO and Co-Founder,
DeepHealth, Inc.,
Haymarket, VA

LUNCH

12:00 PM - 1:45 PM

Networking Lunch 

WORKSHOP

1:45 PM - 4:35 PM

Workshop: Laboratory & Pathology Merger & Acquisition Workshop

1:30 PM – 2:15 PM  
Panel—Lab Valuation Trends: What Factors Drive High Values and Multiples in  Acquisitions of Independent Labs, Genetic Labs, and Pathology Groups

Co-Chairs & Moderators: Richard Cooper, Christal Contini
Panelists: Chris Jahnle, Anil Asnani, Cory Roberts

Richard Cooper, Owner, GIG Consulting

Richard Cooper
JD,
Owner,
GIG Consulting
Chagrin Falls, OH

Christal Contini, Attorney, McDonald Hopkins, Cleveland,OH.

Christal Contini
Practice Chair. M&A,
McDonald Partners,
Cleveland, OH

Christopher Jahnle, Managing Director, Haverford Healthcare Advisors, Radnor, PA

Chris Jahnle
Managing Director,
Haverford Healthcare Advisors,
Radnor, PA

Anil Asnani 
Senior Vice President,
Strategy & Corp Development,
Labcorp,
Burlington, NC

Cory Roberts, MD, President | Sonic Healthcare USA Anatomic Pathology Division, Sonic Healthcare USA, Austin, Texas

Cory Roberts
MD, MBA
CEO,
Sonic Healthcare USA,
Austin, TX

2:15 PM – 3:00 PM
Panel—Preparing for Sale: What Lab Owners Need to Know to Increase Value and Avoid Purchase Price Reductions

Chair & Moderator: Elizabeth Sullivan
Panelists: Jim Billington, Gary Huff, Kevin Hunter

Elizabeth Sullivan, McDonald Hopkins

Elizabeth Sullivan
Chair, National Healthcare Practice,
McDonald Hopkins,
Cleveland, OH

Jim Billington, Chief Executive Officer, Versant Diagnostics

Jim Billington 
CEO,
Versant Diagnostics,
Grapevine, TX

Gary Huff, President Owner of Take Charge LLC, Hampstead, NC.

Gary Huff
President,
Take Charge, LLC.,
Hampstead, NC

Kevin Hunter, CEO, Colaborate

Kevin Hunter
CEO,
Colaborate,
Tampa, FL

3:00 PM – 3:45 PM
Panel—Current Market for Hospital Outreach Transactions: Sales and Management Service Arrangements

Chair & Moderator: Christal Contini
Panelists: Noel Maring, Jeff Myers, Melissa Butterworth 

Christal Contini, Attorney, McDonald Hopkins, Cleveland,OH.

Christal Contini
Practice Chair. M&A,
McDonald Partners,
Cleveland, OH

Noel Maring, Executive Director, Health Systems, LabCorp

Noel Maring
Executive Director, Health Systems
Labcorp,
Washougal, WA

Jeff Meyers, CPA, Vice President, Consulting and Strategic Advisory Services, Accumen

Jeff Myers
CPA,
Vice President, Consulting and Strategic Advisory Services,
Accumen,
Scottsdale, AZ

Melissa Butterworth, President & CEO, Advanced Strategic Partners, Hollywood, FL.

Melissa Butterworth
President,
Advanced Strategic Partners,
West Palm Beach, FL

3:45 PM – 4:35 PM
Panel—Business and Marketing Strategies for Genetic Laboratories in the Current Market

Chair & Moderator: Emily Johnson
Panelists: Patrick Walsh, Valerie Palmieri, Michael Vishnevetsky 

Emily Johnson, Attorney, McDonald Hopkins

Emily Johnson
Member,
McDonald Hopkins LLC,
Chicago, IL

Patrick Walsh, Managing Director, Ziegler

Patrick Walsh
Managing Director,
Ziegler,
Nashville, TN

Valerie Palmieri, CEO & Founder, Momentum Consulting

Valerie Palmieri
CEO/Founder,
Momentum Consulting,
Monroe, CT

Michael Vishnevetsky, SVP Business Development, Fabric Genomics

Michael Vishnevetsky
SVP, Business Development,
Fabric Genomics,
Oakland, CA

BREAKOUT SESSION

1:45 PM - 2:35 PM

What’s New in Pathologist Productivity and Compensation Plus Boosting Profitability through Effective Negotiations with Hospitals and Payers

Robert Tessier, Co-Founder and Panelist, Panel of National Pathology Leaders

Robert Tessier
MPH,
Co-Founder and Panelist,
Panel of National Pathology Leaders,
Woodbridge, CT

AI Sirmon

Al Sirmon
Pathology Practice Advisors, LLC,
Pawleys Island, SC

BREAKOUT SESSION

1:45 PM - 2:35 PM

Opportunities with Clinical Lab 2.0: Adding Value and Creating Clinical and Operational Intelligence to Improve Health Care Delivery

James Crawford, MD, PhD, Emeritus Chair, Department of Pathology and Laboratory Medicine, Northwell Health

James Crawford
MD, PhD
Professor and Chair Emeritus,
Northwell Health
Greenvale, NY

PANEL

1:45 PM - 2:35 PM

Panel: Emerging National Lab Networks Automate Reference Test Ordering/Resulting and Help Labs Generate New Revenue

Chair & Moderator: R. Scott Liff
Panelists: Steven Serota, Mehdi Maghsoodnia, Steve Box, Tim Pletcher

Scott Liff, Principal, Liff Labs Consulting

R. Scott Liff
MBA, MT(ASCP),
Owner/Principle,
LiffLabs,
Chagrin Falls, OH

President and CEO, Wisconsin Diagnostic Laboratories and Atalan, Milwaukee, WI

Steven Serota
President and CEO,
Wisconsin Diagnostics Laboratories and Atalan,
Milwaukee, WI

Mehdi Maghsoodnia, CEO at 1Health

Mehdi Maghsoodnia
CEO,
1Health,
San Francisco, CA

Steve Box, Global Business Development Director, Labgnostic

Steve Box
Global Business Development Director,
Labgnostic Inc.,
Los Angeles, CA

Tim Pletcher, DHA, Executive Director, MiHIN

Tim Pletcher
DHA,
Executive Director,
MiHIN,
Lansing, MI

BREAKOUT SESSION

1:45 PM - 2:35 PM

Open Discussion: Draft LDT Rule, Harmonization of ISO 13485, Memo on Reclassification of Certain Assays, and More

Tim Stenzel, CEO, Grey Haven LLC

Tim Stenzel
CEO,
Grey Haven, LLC.
Crystal, MN

BREAKOUT SESSION

1:45 PM - 2:35 PM

Why Lean Process Design Keeps Bronson Buzzing in Southwest Michigan

Joe Seestadt, Director of Lab Outreach, Bronson Healthcare Group

Joe Seestadt
Director of Lab Outreach,
Bronson Healthcare Group,
Kalamazoo, MI

BREAKOUT SESSION

1:45 PM - 2:35 PM

Is Your Hospital Lab At Risk? Proactive Ways to Educate Administrators on the Value of Lab Testing, Controlling Lab Data, and Improving Patient Outcomes

Jane Hermansen, Director, Outreach and Network Development, Mayo Clinic, Rochester, MN

Jane Hermansen
Director,
Outreach and Network Development,
Mayo Clinic,
Rochester, MN

BREAKOUT SESSION

2:45 PM - 3:35 PM

Prepare Your Playbook to Obtain FDA Approval for Your Laboratory Developed Tests

Jane Pine Wood, JD, Counsel, McDonald Hopkins

Jane Pine Wood 
JD,
Counsel,
McDonald Hopkins,
Dennis, MA

Sheila Walcoff, CEO & Founder, Goldbug Strategies LLC

Sheila Walcoff
JD,
CEO & Founder,
Goldbug Strategies LLC,
Gaithersburg, MD

Valerie Palmieri, CEO & Founder, Momentum Consulting

Valerie Palmieri
CEO/Founder,
Momentum Consulting,
Monroe, CT

BREAKOUT SESSION

2:45 PM - 3:35 PM
3:45 PM - 4:35 PM

Lab CIO and Informatics Roundtable

J Mark Tuthill, Division Head, Pathology Informatics, HFH

J Mark Tuthill
MD,
Division Head, Pathology Informatics,
HFH
Bloomfield Hills, MI

Lee Barnard, CEO and Founder, LDx Healthcare Consulting, LLC

Lee Barnard
CEO and Founder,
LDx Healthcare Consulting, LLC,
Chapel Hill, NC

PANEL

2:45 PM - 3:35 PM

Panel: Developing and Enhancing Win/Win Relationships That Add Value to Key Payers and Health Plans in Your Region

Chair & Moderator: Karen McFadden
Panelists: John Norkett, Kathryn Stough, Clarisa Blattner

Karen McFadden, Retired Senior Vice President at LabCorp.

Karen McFadden
Retired SVP, 
LabCorp,
Chapel Hill, NC

John Norkett, Vice President, Payor Solutions – East, Labcorp

John Norkett
Vice President, Payor Solutions,
Labcorp,
Swarthmore, PA

Kathryn Stough
Principal,
K-H-S Solutions, LLC,
Albuquerque, NM

Clarisa Blattner, Director, MDx Support Service, XIFIN, San Diego, CA

Clarisa Blattner
Senior Director of Revenue and
Payer Optimizations,
XiFin, Inc.
San Diego, CA

BREAKOUT SESSION

2:45 PM - 3:35 PM

Open Discussion: MolDx and Z-Code Update: Current Developments and What’s Coming Next

Gabriel Bien-Willner, Medical Director, M0IDX program, Palmetto GBA

Gabriel Bien-Willner
MD, PhD
Dr.
Palmetto GBA,
Columbia, SC

BREAKOUT SESSION

2:45 PM - 3:35 PM

Healthcare’s Growing Need for Enriched Diagnostic Services: How Demand for Data, Increased Use of AI, and Genome Sequencing Advances Create Opportunities for Labs
William Morice President and CEO Mayo Clinic Laboratories

William Morice
MD, PhD,
President & CEO,
Mayo Clinic Laboratories,
Rochester, MN

PANEL

2:45 PM - 3:35 PM

Panel: Out with the Old–In with the New: How Savvy IVD Marketers Are Converting Millennial Lab Buyers into Customers

Chair & Moderator: Deborah Hewett-Smith
Panelists: Bob McGonnagle, Bruce Carlson, Lynn Replogle

Deborah Hewitt-Smith, Principal, Talking Labs!

Deborah Hewett-Smith
Principal,
Talking Labs!
Spicewood, TX

Bob McGonnagle
Publisher, CAP Today,
College of American Pathologists,
Northfield, IL

Bruce Carlson
Market Research Consultant,
Eye on IVD Newsletter,
Fort Lee, NJ

Lynn Replogle, Senior Director, Commerical Strategy & Market Access, Veranex

Lynn Replogle
Senior Director,
Commercial Strategy & Market Access
Veranex,
Brooklyn, NY

BREAKOUT SESSION

3:45 PM - 4:35 PM

State of Laboratory Medicine and Histopathology in the United Kingdom

David Ricketts
DBMS,
Dr.
Sonic Healthcare UK
Essex, United Kingdom

PANEL

3:45 PM - 4:35 PM

Panel: Important Developments in Laboratory Legal, Regulatory, and Compliance Requirements

Chair & Moderator: Charles Dunham
Panelists: Danielle Sloane, Karen Lovitch, Keith Lefkowitz

Charles Dunham
IV,
Shareholder,
Greenberg Traurig,
Houston, TX

Danielle Sloane, Partner at Bass, Berry & Sims in Nashville, TN

Danielle Sloane
Partner,
Bass, Berry & Sims,
Nashville, TN

Karen Lovitch, Partner, Mintz,

Karen Lovitch
Partner,
Mintz,
Washington, DC

Keith Lefkowitz, Attorney, Hendershot Cowart

Keith Lefkowitz
Attorney,
Hendershot Cowart P.C., 
Houston, TX

BREAKOUT SESSION

3:45 PM - 4:35 PM

Open Discussion: CLIAC Committee Initiatives involving updates to CLIA regulations, Networking Clinical Labs with Public Health Labs, and More
Gregory Sossaman Chairman, Department of Pathology and Laboratory Medicine, Ochsner Health System

Gregory Sossaman
MD,
Chairman, Department of Pathology and Laboratory Medicine,
Ochsner Health System,
New Orleans, LA

James Crawford, MD, PhD, Emeritus Chair, Department of Pathology and Laboratory Medicine, Northwell Health

James Crawford
MD, PhD
Professor and Chair Emeritus,
Northwell Health
Greenvale, NY

BREAKOUT SESSION

3:45 PM - 4:35 PM

Six-Figure Signing Bonuses and Ballooning Compensation Packages: Are These Outliers (or the New Normal) As Pathologist Demand Outpaces Supply?

Rich Cornell, President and Founder, Santé Consulting, Ellisville, MO

Rich Cornell
President and Founder,
Santé Consulting,
Ellisville, MO

BREAKOUT SESSION

3:45 PM - 4:35 PM

Precision Oncology: Serving Urban, Suburban, and Rural Areas with Integrated Pathology, Imaging, and Precision Genomics Services
Lori Brisbin, Vice President, Precision Medicine, Texas Oncology

Lori Brisbin
VP, Precision Medicine-Texas Oncology; COO, Precision Health Informatics, LLC
Texas Oncology, P.A.
Dallas, TX

Trey Schuchart, Precision Medicine IT Products and Services, Texas Oncology

Trey Schuchart
Director, Precision Medicine Systems,
Texas Oncology,
Dallas, TX

GENERAL SESSION

4:45 PM - 5:30 PM

Regulatory Trifecta Coming Soon to All Labs! Anticipating the Federal LDT Rule, Revisions to CLIA Regulations, and Private Payers’ Z-Code Policies for Genetic Claims

Robert Michel, President, The Dark Intelligence Group.

Robert Michel
President, 
The Dark Intelligence Group,
Austin, TX

Wednesday, May 1 (Top)

Don't Miss these Keynote Speakers!

Wednesday General Session — 9:30 AM - 12:00 PM

GENERAL SESSION

9:30 AM - 9:55 AM

Global Perspective on Healthcare Data as the New Driver of Innovation in Diagnostics and Patient Care

Michael Simpson, CEO at Clinisys, Inc.

Michael Simpson
President & CEO,
Clinisys, Inc.
Tucson, AZ

GENERAL SESSION

9:55 AM - 10:15 AM

Digital Pathology’s Adoption Curve in the U.S. and Globally and What’s Coming Next

Joseph Mossel, CEO & Co-Founder, Ibex Medical Analytics

Joseph Mossel
MSc,
CEO & Co-Founder,
Ibex Medical Analytics,
Brookline, MA

AM BREAK

10:15 AM - 10:35 AM

BREAK

GENERAL SESSION

10:35 AM - 10:55 AM

Bringing Artificial Intelligence into Diagnostics and Clinical Practice

Leo Grady, CEO, Jona

Leo Grady
PhD,
CEO, Jona
Darien, CT

GENERAL SESSION

10:55 AM - 11:10 AM

Why the Stage is Set for AI in Healthcare and Diagnostics

Ajit Singh, Managing Director, Artiman Ventures

Ajit Singh
PhD,
Managing Director,
Artiman Ventures,
Palo Alto, CA

GENERAL SESSION

11:10 AM - 12:00 PM

Fireside Chat: Exploring the Intersections and Opportunities with Big Data, Precision Medicine, and Artificial Intelligence in Diagnostics and Clinical Care

Chair & Moderator: Ajit Singh
Panelists: Michael Simpson, Leo Grady, Joseph Mossel 

Ajit Singh, Managing Director, Artiman Ventures

Ajit Singh
PhD,
Managing Director,
Artiman Ventures,
Palo Alto, CA

Michael Simpson, CEO at Clinisys, Inc.

Michael Simpson
President & CEO,
Clinisys, Inc.
Tucson, AZ

Leo Grady, CEO, Jona

Leo Grady
PhD,
CEO, Jona
Darien, CT

Joseph Mossel, CEO & Co-Founder, Ibex Medical Analytics

Joseph Mossel
MSc,
CEO & Co-Founder,
Ibex Medical Analytics,
Brookline, MA

Wednesday Morning — Management Master Classes & Benefactor Sessions

MASTER CLASS

7:30 AM - 8:20 AM

Leveraging Specialty Logistics, Kitting, and Enhanced Informatics to Improve Patient Care, Boost Physician Satisfaction, and Increase Lab Productivity

Sanjesh Sharma, VP of Operations, Natera

Sanjesh Sharma
VP, Operations,
Natera,
San Carlos, CA

Robin Hooker, Senior Vice President - Sales & Marketing, BioTouch

Robin Hooker
Senior Vice President,
Sales & Marketing,
BioTouch,
Midland, GA

MASTER CLASS

7:30 AM - 8:20 AM

Nottingham University Hospitals NHS Trust’s Experience: Realising a Full Digital Pathology Solution Combined with Lean Workflow to Shorten Diagnosis Times, Improve Quality, and Boost Pathologist Productivity

Paul Chenery Nottingham University Hospital

Paul Chenery
Head of Quality, Training & Strategic Improvement Improvement within Pathology, 
Nottingham University Hospital
NHS Trust,
Nottingham, England, UK

MASTER CLASS

7:30 AM - 8:20 AM

Achieving Certification as a Clinical Laboratory Scientist at the Age of 16: One Gen Z’s Journey, along with Insights on Educating Zoomers about Careers in Laboratory Medicine

Isak Schmidley, Clinical Laboratory Scientist, Christus Health

Isak Schmidley
Clinical Laboratory Scientist,
Christus Health,
Coushatta, LA

MASTER CLASS

7:30 AM - 8:20 AM

Using Real-Time Analytics with AI to Align Clinical lab and Pathologist Staffing in Advance of Daily and Weekly Changes in Patient Demand and Test Volumes

Curtiss McNair, VP/GM, American Oncology Network (AON)

Curtiss McNair, Jr.
VP/GM
American Oncology Network (AON)
Fort Myers, FL

John Moyer, Senior Product Director, Lab Insights, hc1

John Moyer
Senior Product Director,
hc1,
Indianapolis, IN

MASTER CLASS

7:30 AM - 8:20 AM

Generating New Revenue Streams: Understanding the Role of Lab Data in Medicare Star Ratings and Risk Adjustment

Anthony Allegretta, PharmD, Regional Vice President, ChenMed

Anthony Allegretta
Regional Vice President,
ChenMed,
Tampa Bay, FL

BENEFACTOR SESSIONS

7:30 AM - 8:20 AM

Data Innovations, Optum, Leica Biosystems, Clinisys

BENEFACTOR SESSION

7:30 AM - 8:20 AM

Data Innovations

Enhancing Clinical Pathology Efficiency: The Role of Instrument Manager in Epic Beaker Integration with Third-Party Middleware Solutions

Join us for an insightful session led by Ron Lum, Epic Beaker Enterprise Architect at Scripps Health, as he delves into the pivotal role of streamlining, simplifying, and optimizing technology to create efficiency in clinical pathology operations. Drawing from his expertise, Ron will share the fundamental concepts of communication between instruments, robotics, and LIS, and how simplifying these communications has a transformative impact on healthcare delivery.

In this session, attendees will gain a comprehensive understanding of how Scripps Health leverages Instrument Manager in a dynamic synergy with Epic Beaker to streamline critical processes. Ron will pose the question: “Why complicate an already complicated system?” and evaluate the necessity of third-party middleware solutions in a rules-based setting driven by Instrument Manager and Epic Beaker.

He will detail the workings of automated systems for managed specimens, shedding light on:

  •  Specimen routing
  •  Critical result reporting
  •  Delta checks
  •  Processing errors mitigation
  •  Quality control mechanisms
  •  Downtime reporting protocols
 
You’ll leave this session empowered with cutting-edge strategies for enhancing efficiency and accuracy in clinical pathology as Ron Lum shares invaluable insights alongside Dan Zimmerman, VP Sales at Data Innovations. 
 
Dan Zimmerman Data Innovations

Dan Zimmerman
VP, Americas Sales,
Data Innovations,
Colchester, VT

Ron Lum
Epic Breaker Enterprise Architect,
Scripps Health,
Colchester, VT

BENEFACTOR SESSION

7:30 AM - 8:20 AM

Optum

Is It Necessary? Lab Trends and Best Practices for Improved Outcomes

Topic Description: According to a recent article published by the National Center for Biotechnology Information, between 20% and 40% of requested tests are deemed inappropriate1. Overutilization and inappropriate lab ordering have significant impacts on both the health of laboratories and patients alike. However, the good news is that by utilizing analytics and implementing a robust decision support system, labs can improve turnaround time, reduce risk, and enhance both clinical and financial outcomes.

In this session, we will explore laboratory ordering-appropriateness trends using exclusive data from CareSelect® Lab, a clinical decision support solution integrated with electronic health records (EHR). We will discuss how various hospitals, health systems, and outpatient clinics have successfully utilized laboratory specific-analytics and evidence-based criteria to make impactful changes through easy interventions and incorporate data-driven best practices into their strategies.

Learning Objectives:

  1. Utilize trends highlighted in the session to recognize areas of improvement within your lab.
  2. Explore the benefits of using analytics to leverage your providers’ ordering data against laboratory-appropriate use criteria to better understand ordering patterns and clearly identify misutilization trends.
  3. Gain insights into the strategies and approaches of organizations that have effectively employed these best practices to improve outcomes.

Kim Waren
Senior Strategist,
Optum,
Eden Prairie, MN

BENEFACTOR SESSION

7:30 AM - 8:20 AM

Leica Biosystems

Optimizing Your Digital Pathology Investment – A Discussion with the Experts

Digital pathology is becoming the new standard of care, transforming the practice of pathology with many laboratories now adopting this technology. Leica Biosystems invites you to discover how to optimize your digital pathology investment. Our distinguished panel of experts will discuss the latest trends and technological advancements driving digital diagnostics and improved patient outcomes; offering fresh insights on how to enhance workflow efficiencies, elevate diagnostic accuracy and create added value to your laboratory.

Eric Glassy, Medical Director, Affiliated Pathologists Medical Group

Eric Glassy
MD, Medical Director,
Affiliated Pathologists Medical Group,
Rancho Dominguez, CA

Sony Wirio, MD, Regional Chief Pathology, Southern California Kaiser Permanente,

Sony Wirio
MD,
Regional Chief Pathology,
Southern California Kaiser Permanente,
Harbor City, CA

Claudine Alexis, Senior Clinical Administrative Director, Northwell Health Laboratories, Greenvale, NY

Claudine Alexis
Senior Clinical Administrative Director,
Northwell Health Laboratories,
Greenvale, NY

Bob McGonnagle
Publisher, CAP TODAY,
College of American Pathologists,
Northfield, IL

BENEFACTOR SESSION

7:30 AM - 8:20 AM

Clinisys

Make Sense of AI and What It Will Mean For Your Lab

In this session, we cut through the hype to understand what AI is and what it isn’t. We’ll discuss the key technologies involved and how they can be applied to address problems within the laboratory. Come gain an understanding of how investing in AI will benefit your lab, as well as where the potential pitfalls lie. This presentation will help you avoid risks, overcome challenges, and determine where to start!

Stacia Sump
Global Product Director of AI and Data Sciences,
Clinisys,
Tucson, AZ

MASTER CLASS

8:30 AM - 9:20 AM

Expanding Your Lab’s Market Access: Leveraging Existing Contracts to Increase Covered Testing Services, Gain Provider Status with New Payers, and Negotiate More Reimbursement

Heather Agostinelli Vice President and Head of Specialty RCM, XiFin, Inc.

Heather Agostinelli
Vice President, Head of Specialty RCM,
XiFin, Inc.
San Diego, CA

Clarisa Blattner, Director, MDx Support Service, XIFIN, San Diego, CA

Clarisa Blattner
Senior Director of Revenue and
Payer Optimizations,
XiFin, Inc.
San Diego, CA

Debbie Windsor

Debbie Windsor
Strategic Partner,

MASTER CLASS

8:30 AM - 9:20 AM

Hit Home Runs with Supply Chain Gainsharing & Effective Lab Stewardship Initiatives: New Tools and Analytics to Drive Down Supply Costs and Improve Physicians’ Utilization of Lab Tests

Lisa Daniel, Director Corporate Lab Services, Parkview Health

Lisa Daniel
MLS (ASCP) BB,
Director Corporate Lab Services,
Parkview Health
Ft. Wayne IN

MASTER CLASS

8:30 AM - 9:20 AM

Collaborating with Pharma companies from Research to the Clinic – Strategies to create new business opportunities for your lab

Julie Ramage, Principal at Harbor Precision Genomics Consulting, Gib Harbor, Washington

Julie Ramage
Principal,
Harbor Precision Genomics Consulting,
Gig Harbor, WA

Jennifer Quigley, Sr. Director Global Precision Diagnostics, Novartis

Jennifer Quigley
Sr. Director,
Global Precision Diagnostics,
Novartis,
Pittsburgh, PA

MASTER CLASS

8:30 AM - 9:20 AM

Today’s Healthcare Consumption: The changing landscape of consumer interest and access to providers, testing and information

Brad Seybert, President/CEO, My One Medical Source (MOMS)

Brad Seybert
President/Founder,
My One Medical Source (MOMS),
Westlake, OH

Scott Madel, President, Boston Heart Diagnostics

Scott Madel
President,
Boston Heart Diagnostics,
Boston, MA

MASTER CLASS

8:30 AM - 9:20 AM

Rapid Whole Genome Sequencing (rWGS): It Improves Patient Outcomes; Some Medicaid Programs Cover rWGS; and How It Generates an ROI for Children’s Hospitals

Michael Vishnevetsky, SVP Business Development, Fabric Genomics

Michael Vishnevetsky
SVP, Business Development,
Fabric Genomics,
Oakland, CA

MASTER CLASS

8:30 AM - 9:20 AM

A Lab Big Data Work Success Story: Combining Lab, EHR, Operations, Financial, and Other Data Now Generating Real-Time Insights to Manage Costs, Improve Outcomes, Collect More Revenue
James Pepoon, Division Administrator, Pathology, Moffitt Cancer Center

James Pepoon
Division Administrator, Pathology
Moffitt Cancer Center
Tampa, FL

Joshua Pathology Business Operations Director, Mofitt Cancer Center

Joshua Rivera 
MBA,
Pathology Business Operations Director,
Moffittt Cancer Center,
Tampa, FL

BENEFACTOR SESSIONS

8:30 AM - 9:20 AM

Quadax, Telcor, Grace

BENEFACTOR SESSION

8:30 AM - 9:20 AM

Quadax

Panel Discussion: Effective Appeal Strategies and Technological Solutions for Increased Reimbursement

No matter the testing method or stage of coverage for your products, claim denials are an unavoidable reality for any laboratory. Appeals are necessary to fight clinical and administrative denials from payers, as well as to rectify payer mistakes made during the claim adjudication process. Preventing and overturning claim denials serves as a key catalyst for boosting revenue and influencing payer behavior, whether by convincing them of medical necessity, influencing coverage policies, or recognizing contractual agreements. Laboratories often adopt a “one-size-fits-all” approach to managing claim denials, overlooking diverse strategies that can be employed based on various factors to ensure successful coverage from payers. In this discussion, we will delve into clinical denials, exploring the timing of appeals, what should be included in an appeal, how to meet payer requirements, and interdisciplinary collaboration within your organization to optimize the appeal process for reimbursement success.

Appeals can also be a very laborious task for a billing team, with determining appeal requirements specific to each payer, managing multiple levels of appeals, crafting comprehensive appeal letters, and dealing with unresponsive payers. However, advancements in technologies offer promising solutions to streamline this process, and we will discuss and review proven techniques and innovative products aimed at reducing costs without jeopardizing reimbursement.

Please join our team of experts, with over 60 years of combined experience in RCM, as we explore appeal strategies for optimizing reimbursement through use of purpose driven analytics.

Chad Miles, Director, Reimbursement Management, Middleburg Heights, OH

Chad Miles
Director,
Reimbursement Management,
Middleburg Heights, OH

Tom Cronin, Vice President,Client Service, Quadax, Inc., Cleveland, OH.

Tom Cronin
SVP,
Revenue Cycle Strategy & Analytics,
Middleburg Heights, OH

Mike Kovacs, SVP, Client Engagement, Middleburg Heights, OH

Mike Kovacs
SVP,
Client Engagement,
Middleburg Heights, OH

Phil Conard, SVP, Solution Strategy and Support, Middleburg Heights, OH

Phil Conard
SVP,
Solution Strategy and Support,
Middleburg Heights, OH

BENEFACTOR SESSION

8:30 AM - 9:20 AM

TELCOR 

RCM Business Intelligence: Are You Tracking the One Key Metric to Know if You’re Leaving Money on the Table?

Every RCM vendor provides revenue cycle reports of some kind. Maybe a dashboard view, maybe a month-end report, maybe a custom report. The dashboard may include colorful charts or impressive graphs. The reports may be directly from the application or from a third-party data warehouse. Are you tracking the one key metric to know if you are leaving money on the table?

As the reimbursement landscape continues to change and more specific information is needed to effectively manage your revenue cycle, there are two questions to ask yourself. Am I getting the right information at the right time? Are my analytics helping me manage my business as effectively as it should?

Executives should not settle for subpar analytics or relying on “this is the way we’ve always done it” mentality. For the success of your laboratory, it is imperative to understand the key metrics every lab should be tracking. This includes knowing how your billing team is performing. Sometimes the effort isn’t worth the payout. Alternatively, you might be leaving money on the table, which could make a big difference. The question is, do you know?

During this presentation, laboratory executives will:

  • Learn how payer requirements affect reimbursement and show ways to determine if your processes are effective or if they need to change.
  • Have insight into appeals to determine which are worth pursuing by understanding the cost versus success.
  • For new labs, know what to track to set yourself up for maximum reimbursement.
  • For existing labs, how to identify opportunities for additional reimbursement dollars.
  • Realize how productivity reports provide deeper insight into operational costs and how this information can impact your overall profitability.
Sarah Stewart, Vice President Revenue Cycle Services, TELCOR

Sarah Stewart
Vice President Revenue Cycle Services,
TELCOR,
Lincoln, NE

Darla Wanitschke, Director of Customer Success, TELCOR

Darla Wanitschke
Director of Customer Success,
TELCOR,
Lincoln, NEE

BENEFACTOR SESSION

8:30 AM - 9:20 AM

Grace Health Technology

Leveraging Advanced Technology to Overcome Laboratory Hurdles: A Path to Enhanced Efficiency, Financial Performance, and Scalability

Explore the transformative impact of technology on laboratory operations in the session, “Leveraging Advanced Technology to Overcome Laboratory Hurdles: A Path to Enhanced Efficiency, Financial Performance, and Scalability.” This session delves into how innovative technology integrations can revolutionize lab practices, enhancing efficiency, financial performance, and scalability.

Attendees will have the opportunity to learn from industry experts who will showcase real-world examples and practical strategies for maximizing operational effectiveness and financial viability. Tailored for laboratory professionals, this session offers actionable insights to overcome challenges and drive success in the competitive healthcare landscape.

Key discussion points will include identifying common laboratory hurdles while harnessing advanced technology for efficiency, maximizing financial performance, and achieving scalability and adaptability. Don’t miss the opportunity to gain valuable knowledge and enhance your laboratory operations.

Villafana Sapphire , Director of Business Development, Grace Health Technology

Sapphire Villafana
Director of Business Development,
Grace Health Technology,
Delray Beach, FL

Ashley Adams Executive Vice President, Grace Health Technology, Delray Beach, FL

Ashley Adams
Executive Vice President,
Grace Health Technology,
Delray Beach, FL

LUNCH

12:00 PM - 1:30 PM

Networking Lunch 

BREAKOUT SESSION

1:30 PM - 2:20 PM

A Winning Use Case for Digital Pathology

Esther Abels, CEO, SolarisRTC, LLC

Esther Abels
CEO,
SolarisRTC, LLC
Boston, MA

BREAKOUT SESSION

1:30 PM - 2:20 PM

Artificial Intelligence: Regulatory and other Legal Issues. A primer for Clinical Laboratories

Roger Klein
MD, JD,
Faculty Fellow,
Center for Law, Science & Innovation, ASU Law,
Beachwood, OH

PANEL

1:30 PM - 2:20 PM

PANEL: Clinical Laboratory Certification and Accreditation: New Developments with CLIA, Most Common Deficiencies, and Making Your Lab “Assessment Ready”

Chair & Moderator: Nora Hess
Panelists: Carlyn Mathews, Denise Driscoll, Kathy Nucifora, Elia Mears

Nora Hess, Senior Consultant at Accumen.

Nora Hess
MBA, MT (ASCP), PMP,
Senior Consultant,
Accumen,
Sarasota, FL

Carlyn Matthews, Clinical Program Manager at A2LA

Carlyn Mathews
Clinical Program Manager,
A2LA,
Frederick, MD

Denise Driscoll, Senior Director, Accreditation and Regulatory Affairs, College of American Pathologists

Denise Driscoll
MS, MT(ASCP)SBB,
Senior Director, 
Accreditation & Regulatory Affairs,
College of American Pathologists,
Northfield, IL

Kathy Nucifora Chief Operating Officer Cola, Inc.

Kathy Nucifora
MPH, MT (ASCP),
Chief Operating Officer,
COLA Inc.,
Columbia, MD

Elia Mears, The Joint Commission

Elia Mears
MS MLS(ASCP)SM,
Laboratory Field Surveyor – Laboratory Accreditation Program,
The Joint Commission,
Oakbrook Terrace, IL

BREAKOUT SESSION

1:30 PM - 2:20 PM

Building the Diagnostic Center at UTMB for all of Healthcare

Michael Laposata, Professor and Chair of Pathology, University of Texas Medical Branch - Galveston

Michael Laposata
Professor and Chair of Pathology,
University of Texas Medical Branch – Galveston,
Galveston, TX

BREAKOUT SESSION

1:30 PM - 2:20 PM

How labs can adopt AI / ML technologies Now to Drive Tangible Improvements in Care Delivery & Cost Reduction

Brad Bostic
Chairman & CEO,
hc1 Insights
Indianapolis, IN

BREAKOUT SESSION

1:30 PM - 2:20 PM

Preparing for the LDT Upheaval – One Company’s Experience with Regulatory Discretion

Don Rule CEO, Translational Medicine

Don Rule
MBA,
CEO, Translational Software,
Mercer Island, WA

BREAKOUT SESSION

2:20 PM - 3:10 PM

Lab Automation’s Next Generation: Achieving ROI, Boosting Staff Morale, Slashing TAT, and Adding Value to Physicians and Patients

Jessica Isaac, Executive Director, Pathology Laboratory, IU Health

Jessica Isaac
MHA, MLS(ASCP)CM
Executive Director,
Pathology Laboratory,
IU Health,
Indianapolis, IN

PANEL

2:20 PM - 3:10 PM

Panel: Current State and Future Directions for Digital Pathology, from Histology and Scanning to Pathologist Workflow and AI-Powered Analysis of Whole Slide Images

Chair & Moderator: Esther Abels
Panelists: Lisa-Jean Clifford, Vaishali Pannu, Leo Grady

Esther Abels, CEO, SolarisRTC, LLC

Esther Abels
CEO,
SolarisRTC, LLC
Boston, MA

Lisa-Jean Clifford, COO & Chief Strategy Officer, Gestalt Diagnostics, Spokane, Wash

Lisa-Jean Clifford
COO & Chief Strategy Officer,
Gestalt Diagnostics,
Spokane, WA

Vaishali Pannu, Vice President - Digital Pathology, Caris Life Sciences

Vaishali Pannu
PhD,
Vice President – Digital Pathology,
Caris Life Sciences,
Phoenix, AZ

Leo Grady, CEO, Jona

Leo Grady
PhD,
CEO, Jona,
Darien, CT

BREAKOUT SESSION

2:20 PM - 3:10 PM

Using ISO 15189: Medical Laboratory Accreditation to Advance Patient Care, Sustain Lab Staff’s Quality Culture, and Be CLIA inspection-Ready

Mike Baron Wisconsin Diagnostic Laboratories

Mike Baron
Executive Director of Laboratory Operations,
Wisconsin Diagnostic Laboratories
Milwaukee, WI

BREAKOUT SESSION

2:20 PM - 3:10 PM

Reenergizing your Performance Culture: Engaging Mindsets, Skillsets, and Toolsets

Linda Mchale Assistant Vice President, Core Laboratory and Integration, Altrium Health, speaker at the Executive War College

Linda McHale
MBA, MLS (ASCP)
Asst. Vice President, Lab Operations,
ACL Laboratories, Advocate Health,
Charlotte, NC

Shika Dharamrup speaker at the Executive War College

Shikha Dharamrup
Director of Lab Operations,
ACL Laboratories, Advocate Health,
Charlotte, NC

GENERAL SESSION

3:20 PM - 3:40 PM

Extracting the Important Lessons from the Executive War College 2024

Robert Michel, President, The Dark Intelligence Group.

Robert Michel
President, 
The Dark Intelligence Group,
Austin, TX

Special Learning Opportunities

Choose From These
Exceptional Workshops
(Back to Top)

Post-Conference Workshops

To see session topics and speakers, select the underlined title for that workshop

Thursday, May 2

Who Attends the Executive War College

Health Systems and Hospital Clinical Laboratory and Pathology Leadership

Hospital C-Suite Administrators

Laboratory Vice Presidents

Pathology Lab Directors/Administrators

Laboratory Directors

Molecular and Genetic Lab Leaders

Precision Medicine & Genetic Program Directors/Administrators

Laboratory Section Managers/Leaders/Supervisors

Representative Labs:

  • ACL Laboratories/Advocate Health
  • Cleveland Clinic Laboratories
  • Medical University of South Carolina
  • Johns Hopkins Medicine
  • Baptist Health South Florida
  • Banner Health
  • Intermountain Health Outreach Labs
  • Baylor Scott & White Health
  • Cedars Sinai
  • Santa Monica UCLA Medical Center
  • Fabric Genomics
  • Kaiser Permanente

Independent Laboratories and Pathology Groups

Laboratory Owners/C-Suite/Vice Presidents/Directors

Pathology Group Owners/Directors

Pathology Group Practice Administrators

Physician Group Lab Owners/Directors

Public Health/Population Health VP’s/Directors

Life Sciences/Research Labs

Representative Labs:

  • Mayo Clinic Laboratories
  • ARUP (Reference Lab)
  • LabCorp (Reference Lab)
  • TriCore (Reference Lab)
  • GeneDx
  • Sonic Labs (Reference Lab)
  • Michigan Pathology Specialists (Pathologist Group)
  • Pacific Pathology Labs (Pathology Group)
  • NorDX (Animal Reference Lab)
  • Novartis (Research Pharm (Life Sciences)
  • AstraZeneca (Pharm/Life Sciences)
  • Caris Life Sciences (Pharm/Life Sciences)
  • Sonora Quest (Population Health Division)

Partners and Suppliers to Laboratory and Pathology Groups

In Vitro Diagnostic Manufacturers

LIS/Pathology LIS/LIMS/RCM/IT

Diagnostic Instrument, Product & Technology

Informatics Products and Services

Suppliers of Automation, Analyzers, and Assays

Revenue Cycle Management (RCM), Coding, Billing, and Collections

Legal, Regulatory & Compliance

Representative Companies:

  • Abbott (Diagnostics)
  • Epic Corporation (EMR/LIS)
  • Clinisys LIS
  • Cerner LIS
  • Telcor (Technology)
  • XIFIN (Technology/Informatics)
  • LifePoint Informatics
  • Change Health Care (RCM/billing)
  • HC1 (RCM)
  • Diagnostic Laboratory Services, Inc. (RCM)
  • COLA (Regulatory)
  • College of American Pathologists (Regulatory)
  • Beckman Diagnostics (Diagnostics)
  • Bio-Rad Laboratories (Diagnostics)
  • Hologic (Diagnostics)
  • Cardinal Health (Product & Technology)
  • Davis Wright Tremaine LLP (Legal)